secwatch.observer — SEC 8-K summary
======================================

Issuer:     Y-mAbs Therapeutics, Inc. (—)
CIK:        0001722964
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001104659-24-054165
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Gérard Ber to resign from Y-mAbs board effective June 10, 2024
-----------------------------------------------------------------------

- Gérard Ber, Ph.D., notified Y-mAbs that he will resign from the Board of Directors, effective June 10, 2024.
- Resignation is not due to any disagreement with the Company regarding operations, policies, or practices.
- Dr. Ber will remain available for consultation and advice following his resignation.
- The Company thanked Dr. Ber for his commitment and service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722964/000110465924054165/0001104659-24-054165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722964/000110465924054165/tm2412919d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-054165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer